New Novavax vaccine is “highly effective” against UK Covid variant

Published on January 29, 2021 by

A fourth vaccine could be approved shortly in the UK after trials showed it was particularly effective against the UK coronavirus variant.

Novavax is a US vaccine being produced in the UK on Teeside. The British government has 60 million doses on order.

Meanwhile the UK has insisted that existing vaccine supplies won’t be interrupted despite a continuing row between AstraZeneca and the European Union over shortages.

Almost seven and a half million people have now had at least one dose of the vaccine in the UK – that’s far higher than countries across the EU.

The row was sparked when AstraZeneca said it wouldn’t be able to deliver all the doses promised to the EU by March.

The EU has called for some of the vaccines made in the UK to be diverted and warned it could resort to legal action.

France, Portugal and Germany are just some of the EU member states struggling to get hold of enough vaccine supplies. Vaccinations are having to be postponed before the roll out has really begun.

Sophie Raworth presents BBC News at Ten reporting by medical editor Fergus Walsh and by Jenny Hill in Germany.

Category Tag
0 0 votes
Article Rating
Notify of

Inline Feedbacks
View all comments